Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

Novo won the U.S. Food and Drug Administration's approval in 2024 to use Wegovy to reduce the risk of cardiovascular death, ...

A new once-daily weight loss pill developed by Novo Nordisk has shown strong results in helping people with obesity lose ...

Four in five people put the weight back on after coming of weight loss jabs, new research has suggested today-and they're not ...

Ann White, from Northampton, had spent three decades yo-yo dieting, constantly flitting between highly restrictive diets and ...

Orforglipron works by helping the body release insulin and lower another hormone called glucagon. This helps reduce blood ...

High cholesterol causes a sticky form of fat to build up in the arteries, blocking blood flow. Left untreated, it can raise ...

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.